This is a retrospective analysis on apomorphine in a large Dutch cohort.
Long-term outcomes of apomorphine on motor and non-motor symptoms were reviewed.
The efficacy on motor symptoms seems to be directly related to LEDD reduction.
Apomorphine can be prescribed safely to PD patients with pre-existing visual hallucinations.
Apomorphine seems to improve nighttime sleeping problems.